Applied Integrin Sciences developed a novel and exciting technology platform to discover new, first in class protein therapeutic drugs. Two lead cancer therapeutic candidates discovered from this platform are in development. The Company has active business development programs available in the following areas:
- Research Collaborations
- Lead Candidate Product Development Collaborations
- Candidate Licensing
- New Therapeutic Candidate Discovery
- Technology Platform Access
We welcome interest from prospective collaborators, corporate partners and investors, and others who want to know more about our company, our science, and the novel cancer therapeutic recombinant proteins we are developing. Contact us at:
Applied Integrin Sciences, Inc.
Attn. President and CEO
10940 Wilshire Boulevard, Suite 1600
Los Angeles, CA 90024